Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Surmodics, Inc. - Common Stock (NQ:SRDX)

28.32 +0.89 (+3.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Surmodics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Surmodics to Host Virtual Annual Meeting of Shareholders
From Surmodics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 333.5% to $2.79 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 19.4... 
Via Benzinga
Surmodics Reports First Quarter Fiscal 2022 Results
From Surmodics, Inc.
Via Business Wire
Surmodics to Webcast First Quarter Fiscal 2022 Earnings Conference Call on February 3
From Surmodics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... 
Via Benzinga
Surmodics: Q1 Earnings Insights
  Surmodics (NASDAQ:SRDX) reported its Q1 earnings results on Thursday, February 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter. 
Via Benzinga
Sidoti Winter Virtual Small Cap Investor Conference
- Presentation Times and Weblinks Released for Over 70 Presenting Companies - Wednesday and Thursday, January 19th-20th, 2022 NEW YORK, NY / ACCESSWIRE / January 18, 2022 / Sidoti & Company, LLC has... 
From Sidoti & Company, LLC
Via AccessWire
Surmodics to Present at Sidoti & Company Virtual Investor Conference
From Surmodics, Inc.
Via Business Wire
Surmodics Inc (SRDX) Q4 2021 Earnings Call Transcript
SRDX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance
From Surmodics, Inc.
Via Business Wire
Surmodics to Webcast Fourth Quarter Fiscal 2021 Earnings Conference Call on November 10
From Surmodics, Inc.
Via Business Wire
Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter
From Surmodics, Inc.
Via Business Wire
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
Surmodics Inc (SRDX) Q3 2021 Earnings Call Transcript
SRDX earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Recap: Surmodics Q3 Earnings
Shares of Surmodics (NASDAQ:SRDX) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share fell 180.95% year over year to ($0.17),... 
Via Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... 
Via Benzinga
Surmodics Reports Third Quarter Fiscal 2021 Results and Updates Fiscal 2021 Revenue and EPS Guidance
From Surmodics, Inc.
Via Business Wire
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
Surmodics Announces Successful First Patient Use of Pounce™ Thrombectomy System
From Surmodics, Inc.
Via Business Wire
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
From Surmodics, Inc.
Via Business Wire
Surmodics Builds Thrombectomy Portfolio with Acquisition of Vetex Medical Limited
From Surmodics, Inc.
Via Business Wire
Surmodics Inc (SRDX) Q2 2021 Earnings Call Transcript
SRDX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Recap: Surmodics Q2 Earnings
Shares of Surmodics (NASDAQ:SRDX) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 1450.00% over the past year to $0.62... 
Via Benzinga
Surmodics Reports Second Quarter Fiscal 2021 Results and Issues Fiscal 2021 Revenue and EPS Guidance
From Surmodics, Inc.
Via Business Wire
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
Earnings Scheduled For April 28, 2021
Companies Reporting Before The Bell • M/I Homes (NYSE:MHO) is likely to report quarterly earnings at $1.51 per share on revenue of $758.77 million. • Melco... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.